Daniel S Peeper (D S Peeper)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 26

Top Topics

Metastatic Colorectal Cancer

Squamous Cell Carcinoma

Dendritic Cells

Histone Deacetylase

Top Venues

The EMBO journal

Nature communications

The Journal of experimental medicine

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal 42 (5) (2023)
Sebastiaan M Schieven, Joleen J H Traets, Alex V Vliet, Martijn V Baalen, Ji-Ying Song, Marcos Da Silva Guimaraes, Thomas Kuilman, Daniel S Peeper
The Elongin BC complex negatively regulates AXL and marks a differentiated phenotype in melanoma. Molecular cancer research : MCR (2023)
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, Maarten A Ligtenberg, Stephanie Blankenstein, Beaunelle de Bruijn, Dennie T Frederick, Juliana C N Kenski, Mara Parren, Marieke Brüggemann, Max F Madu, Elisa A Rozeman, Ji-Ying Song, Hugo Mark Horlings, Christian U Blank, Alexander C J van Akkooi, Keith T Flaherty, Genevieve Marie Boland, Daniel S Peeper
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance. Nature communications 14 (1) (2023)
Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal (2023)
Irene L M Reijers, Disha Rao, Judith M Versluis, Alexander M Menzies, Petros Dimitriadis, Michel W J M Wouters, Andrew J Spillane, Willem M C Klop, Annegien Broeks, Linda J W Bosch, Marta Lopez-Yurda, Winan J van Houdt, Robert V Rawson, Lindsay G Grijpink-Ongering, Maria Gonzalez, Sten Cornelissen, Jasper Bouwman, Joyce Sanders, Elsemieke I Plasmeijer, Yannick S Elshot, Richard A Scolyer, Bart A van de Wiel, Daniel S Peeper, Alexander C J van Akkooi, Georgina V Long, Christian U Blank
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma. The Journal of experimental medicine 220 (5) (2023)
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, Maarten A Ligtenberg, Stephanie Blankenstein, Beaunelle de Bruijn, Dennie T Frederick, Juliana C N Kenski, Mara Parren, Marieke Brüggemann, Max F Madu, Elisa A Rozeman, Ji-Ying Song, Hugo Mark Horlings, Christian U Blank, Alexander C J van Akkooi, Keith T Flaherty, Genevieve Marie Boland, Daniel S Peeper
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance. Nature communications 14 (1) (2023)
Irene L M Reijers, Disha Rao, Judith M Versluis, Alexander M Menzies, Petros Dimitriadis, Michel W J M Wouters, Andrew J Spillane, Willem M C Klop, Annegien Broeks, Linda J W Bosch, Marta Lopez-Yurda, Winan J van Houdt, Robert V Rawson, Lindsay G Grijpink-Ongering, Maria Gonzalez, Sten Cornelissen, Jasper Bouwman, Joyce Sanders, Elsemieke I Plasmeijer, Yannick S Elshot, Richard A Scolyer, Bart A van de Wiel, Daniel S Peeper, Alexander C J van Akkooi, Georgina V Long, Christian U Blank
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma. The Journal of experimental medicine 220 (5) (2023)
Esmée P Hoefsmit, Paula T van Royen, Disha Rao, Johanna A Stunnenberg, Petros Dimitriadis, Cor Lieftink, Ben Morris, Elisa A Rozeman, Irene L M Reijers, Ruben Lacroix, Huma Shehwana, Maarten A Ligtenberg, Roderick L Beijersbergen, Daniel S Peeper, Christian U Blank
Inhibitor of apoptosis proteins (IAP) antagonist induces T-cell proliferation after cross-presentation by dendritic cells. Cancer immunology research (2023)
Irene L M Reijers, Disha Rao, Judith M Versluis, Alexander M Menzies, Petros Dimitriadis, Michel W J M Wouters, Andrew J Spillane, Willem M C Klop, Annegien Broeks, Linda J W Bosch, Marta Lopez-Yurda, Winan J van Houdt, Robert V Rawson, Lindsay G Grijpink-Ongering, Maria Gonzalez, Sten Cornelissen, Jasper Bouwman, Joyce Sanders, Elsemieke I Plasmeijer, Yannick S Elshot, Richard A Scolyer, Bart A van de Wiel, Daniel S Peeper, Alexander C J van Akkooi, Georgina V Long, Christian U Blank
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma. The Journal of experimental medicine 220 (5) (2023)
Disha Rao, Johanna A Stunnenberg, Ruben Lacroix, Petros Dimitriadis, Joanna Kaplon, Fabienne Verburg, Paula T van van Royen, Esmée P Hoefsmit, Kathrin Renner, Christian U Blank, Daniel S Peeper
Acidity-mediated induction of FoxP3 + regulatory T cells. European journal of immunology (2023)
Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal 42 (5) (2023)
Irene L M Reijers, Disha Rao, Judith M Versluis, Alexander M Menzies, Petros Dimitriadis, Michel W J M Wouters, Andrew J Spillane, Willem M C Klop, Annegien Broeks, Linda J W Bosch, Marta Lopez-Yurda, Winan J van Houdt, Robert V Rawson, Lindsay G Grijpink-Ongering, Maria Gonzalez, Sten Cornelissen, Jasper Bouwman, Joyce Sanders, Elsemieke I Plasmeijer, Yannick S Elshot, Richard A Scolyer, Bart A van de Wiel, Daniel S Peeper, Alexander C J van Akkooi, Georgina V Long, Christian U Blank
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma. The Journal of experimental medicine 220 (5) (2023)
Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal 42 (5) (2023)
Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal 42 (5) (2023)
Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal 42 (5) (2023)
Kai Song, Jenna K Minami, Arthur Huang, Siavash R Dehkordi, Shirley H Lomeli, Jens Luebeck, Mark H Goodman, Gatien Moriceau, Oscar Krijgsman, Prashanthi Dharanipragada, Trevor Ridgley, William P Crosson, Jesus Salazar, Eli Pazol, Gabriel Karin, Rachana Jayaraman, Nikolas G Balanis, Salwan Alhani, Kyle Sheu, Johanna Ten Hoeve, Amelia Palermo, Stephen E Motika, T Niroshi Senaratne, Kim H Paraiso, Paul J Hergenrother, P Nagesh Rao, Asha S Multani, Daniel S Peeper, Vineet Bafna, Roger S Lo, Thomas Glen Graeber
Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges. Cancer discovery 12 (4) (2022)
Georgi Apriamashvili, David W Vredevoogd, Oscar Krijgsman, Onno B Bleijerveld, Maarten A Ligtenberg, Beaunelle de Bruijn, Julia Boshuizen, Joleen J H Traets, Daniela D'Empaire Altimari, Alex van Vliet, Chun-Pu Lin, Nils L Visser, James D Londino, Rebekah Sanchez-Hodge, Leah E Oswalt, Selin Altinok, Jonathan C Schisler, Maarten Altelaar, Daniel S Peeper
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling. Nature communications 13 (1) (2022)
Abhijeet Pataskar, Julien Champagne, Remco Nagel, Juliana Kenski, Maarja Laos, Justine Michaux, Hui Song Pak, Onno B Bleijerveld, Kelly Mordente, Jasmine Montenegro Navarro, Naomi Blommaert, Morten M Nielsen, Domenica Lovecchio, Everett Stone, George Georgiou, Mark Cornelis de Gooijer, Olaf van Tellingen, Maarten Altelaar, Robbie P Joosten, Anastassis Perrakis, Johanna Olweus, Michal Bassani-Sternberg, Daniel S Peeper, Reuven Agami
Tryptophan depletion results in tryptophan-to-phenylalanine substitutants. Nature 603 (7902) (2022)
Joris L Vos, Joris B W Elbers, Oscar Krijgsman, Joleen J H Traets, Xiaohang Qiao, Anne M van der Leun, Yoni Lubeck, Iris M Seignette, Laura A Smit, Stefan M Willems, Michiel W M van den Brekel, Richard Dirven, M Baris Karakullukcu, Luc Karssemakers, W Martin C Klop, Peter J F M Lohuis, Willem H Schreuder, Ludi E Smeele, Lilly-Ann van der Velden, I Bing Tan, Suzanne Onderwater, Bas Jasperse, Wouter V Vogel, Abrahim Al-Mamgani, Astrid Keijser, Vincent van der Noort, Annegien Broeks, Erik Hooijberg, Daniel S Peeper, Ton N M Schumacher, Christian U Blank, Jan Paul de Boer, John B A G Haanen, Charlotte L Zuur
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma. Nature communications 12 (1) (2021)
E A Rozeman, Esmée P Hoefsmit, I L M Reijers, Robyn P M Saw, J M Versluis, O Krijgsman, Petros Dimitriadis, K Sikorska, B A van de Wiel, H Eriksson, M Gonzalez, A Torres Acosta, L G Grijpink-Ongering, Kerwin F Shannon, John B A G Haanen, J Stretch, S Ch'ng, Omgo E Nieweg, H A Mallo, S Adriaansz, R M Kerkhoven, S Cornelissen, A Broeks, W M C Klop, C L Zuur, W J van Houdt, Daniel S Peeper, Andrew J Spillane, A C J van Akkooi, Richard A Scolyer, Ton N M Schumacher, A M Menzies, G V Long, Christian U Blank
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma. Nature medicine 27 (2) (2021)
Oscar Krijgsman, Kristel Kemper, Julia Boshuizen, David W Vredevoogd, Elisa A Rozeman, Sofia Ibanez Molero, Beaunelle de Bruijn, Paulien Cornelissen-Steijger, Aida Shahrabi, Martin Del Castillo Velasco-Herrera, Ji-Ying Song, Maarten A Ligtenberg, Roelof J C Kluin, Thomas Kuilman, Petra Ross-MacDonald, John B A G Haanen, David J Adams, Christian U Blank, Daniel S Peeper
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Osnat Bartok, Abhijeet Pataskar, Remco Nagel, Maarja Laos, Eden Goldfarb, Deborah Hayoun, Ronen Levy, Pierre-Rene Körner, Inger Z M Kreuger, Julien Champagne, Esther A Zaal, Onno B Bleijerveld, Xinyao Huang, Juliana Kenski, Jennifer A Wargo, Alexander Brandis, Yishai Levin, Orel Mizrahi, Michal Alon, Sacha Lebon, Weiwen Yang, Morten M Nielsen, Noam Stern-Ginossar, Maarten Altelaar, Celia R Berkers, Tamar Geiger, Daniel S Peeper, Johanna Olweus, Yardena Sameuls, Reuven Agami
Anti-tumour immunity induces aberrant peptide presentation in melanoma. Nature 590 (7845) (2020)
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, Maarten A Ligtenberg, Stephanie Blankenstein, Beaunelle de Bruijn, Dennie T Frederick, Juliana C N Kenski, Mara Parren, Marieke Brüggemann, Max F Madu, Elisa A Rozeman, Ji-Ying Song, Hugo Mark Horlings, Christian U Blank, Alexander C J van Akkooi, Keith T Flaherty, Genevieve Marie Boland, Daniel S Peeper
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance. Nature communications 11 (1) (2020)
Alireza Azimi, Stefano Caramuta, Brinton Seashore-Ludlow, Johan Boström, Jonathan L Robinson, Fredrik Edfors, Rainer Tuominen, Kristel Kemper, Oscar Krijgsman, Daniel S Peeper, Jens B Nielsen, Johan Hansson, Suzanne Egyhazi Brage, Mikael Altun, Mathias Uhlen, Gianluca Maddalo
Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Molecular systems biology 14 (3) (2018)
Julia Boshuizen, Louise A Koopman, Oscar Krijgsman, Aida Shahrabi, Elke Gresnigt- van den Heuvel, Maarten A Ligtenberg, David W Vredevoogd, Kristel Kemper, Thomas Kuilman, Ji-Ying Song, Nora Pencheva, Jens Thing Mortensen, Marnix Geukes Foppen, Elisa A Rozeman, Christian U Blank, Maarten L Janmaat, David Satijn, Esther C W Breij, Daniel S Peeper, Paul W H I Parren
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors. Nature medicine 24 (2) (2018)
Thomas Kuilman, Daniel S Peeper
Phenotypic diversity drives paracrine drug tolerance. EMBO molecular medicine 9 (8) (2018)